• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Am J Infect Control . Impact of vaccination and the omicron variant on COVID-19 severity in pregnant women

tetano

Editor, Senior Moderator
Am J Infect Control


. 2022 Jul 31;S0196-6553(22)00592-2.
doi: 10.1016/j.ajic.2022.07.023. Online ahead of print.
Impact of vaccination and the omicron variant on COVID-19 severity in pregnant women


Haemin Kim[SUP] 1 [/SUP], Hyo-Shin Kim[SUP] 1 [/SUP], Hyun Mi Kim[SUP] 1 [/SUP], Mi Ju Kim[SUP] 1 [/SUP], Ki Tae Kwon[SUP] 2 [/SUP], Hyun-Hwa Cha[SUP] 3 [/SUP], Won Joon Seong[SUP] 4 [/SUP]



Affiliations

Abstract

We compared the clinical course of pregnant women with coronavirus disease 2019 (COVID-19) before and after the emergence of the omicron variant and based on vaccination status. We retrospectively reviewed the electronic medical charts of 224 patients and 82 deliveries from November 1, 2020, to March 7, 2022; of these, 42% were diagnosed during the omicron dominance period. Disease severity and morbidity of COVID-19 were significantly decreased during the omicron era. The vaccination rates among the patients were higher after omicron emergence (31.9%) than before (6.9%). Overall, 4.1% and 25% of patients had severe symptoms, and 2.6% and 16.2% required oxygen therapy in the vaccination and non-vaccination groups, respectively. Overall, patients had a more favorable clinical course in the omicron era; moreover, vaccinated patients were better protected than non-vaccinated patients, indicating the importance of vaccination against COVID-19.

Keywords: COVID-19; Omicron; Pregnancy.
 
Back
Top Bottom